Extrafollicular and germinal-centre B-cell responses
- Process
Activated B cells take two roads: a fast one that makes quick, weak antibody, and a slow one that trains B cells into strong antibody and lasting memory.
What it is
After meeting antigen and helper T cells, B cells either form an extrafollicular focus that quickly makes short-lived plasma cells, or enter a follicle with follicular helper T cells and build a germinal centre. In the germinal centre B cells mutate their antibody genes and compete for antigen and T-cell help; the winners become high-affinity long-lived plasma cells and memory B cells. Germinal centres explain lasting vaccine protection and the origin of several lymphomas.
Step by step
- B cells bind antigen in the follicle and move to the border with the T-cell zone, where they meet activated helper T cells.
- Extrafollicular route: some B cells become plasmablasts in the medullary cords or red pulp; they make mostly IgM of low affinity within days.
- Germinal-centre route: other B cells and follicular helper T cells (Tfh) enter the follicle and form a germinal centre about a week after exposure.
- Dark zone: B cells (centroblasts) proliferate fast and AID introduces point mutations in variable genes (somatic hypermutation).
- Light zone: B cells (centrocytes) test their new receptor on antigen held by follicular dendritic cells and compete for Tfh help (CD40L, IL-21).
- Cells with higher affinity survive and cycle back; the rest die by apoptosis and are eaten by tingible-body macrophages.
- Exit: long-lived plasma cells home to the bone marrow, and memory B cells recirculate.
Extrafollicular vs germinal-centre response
| Feature | Extrafollicular | Germinal centre |
|---|---|---|
| Timing | First days | From about the end of the first week; lasts weeks |
| Antibody | Mostly IgM, some switched; low affinity | Switched isotypes, high affinity |
| Plasma cells | Short-lived | Long-lived (bone marrow niches) plus memory B cells |
| Key helpers | Activated helper T cells, innate signals | Tfh cells, follicular dendritic cells |
| Transcription factors | Blimp-1 (plasma cell programme) | BCL6 (germinal-centre B cells and Tfh) |
Markers
- Germinal centre: CD10, BCL6, high Ki-67
- Reactive follicles: BCL2 negative
- Plasma cells: CD138
- Tfh: CXCR5, PD-1
Clinical notes
- Follicular lymphoma: t(14;18) puts BCL2 under the immunoglobulin promoter, so germinal-centre B cells escape apoptosis; neoplastic follicles are BCL2⁺, reactive ones are BCL2⁻.
- Burkitt lymphoma and germinal-centre-type large B-cell lymphoma derive from germinal-centre B cells (CD10⁺, BCL6⁺).
- Hyper-IgM syndromes (CD40L or AID defects) lack proper germinal centres: high IgM, no switched isotypes.
- Reactive follicular hyperplasia shows polarised germinal centres with tingible-body macrophages, a sign of a benign response.
Common traps
- Somatic hypermutation happens in the bone marrow during B-cell development: it happens in germinal centres, after antigen exposure, driven by AID.
- Follicular dendritic cells are ordinary dendritic cells that present peptide on MHC: they are stromal cells that hold intact antigen for B cells, not peptides for T cells.
- BCL2-positive germinal centres are normal: reactive germinal-centre B cells switch BCL2 off, so a BCL2⁺ follicle suggests follicular lymphoma.
- The first antibody after a vaccine is already high-affinity: early antibody comes from the extrafollicular route and is mostly low-affinity IgM.
Test yourself
Think of the answer, then tap the question to see it.
Why does the affinity of serum antibody rise over the weeks after a vaccine?
In germinal centres AID mutates the variable genes, and only B cells that bind antigen on follicular dendritic cells best win Tfh help and survive (affinity maturation).
A child with CD40L deficiency has high IgM but no IgG or IgA. Which step of this page fails?
Tfh cells cannot give CD40L to B cells, so germinal centres and class switching do not form: hyper-IgM syndrome.
How does BCL2 staining help distinguish reactive follicles from follicular lymphoma?
Reactive germinal-centre B cells are BCL2 negative so that losers can die; follicular lymphoma cells are BCL2 positive because t(14;18) keeps BCL2 on.
What do tingible-body macrophages in a germinal centre tell you?
That many B cells are dying by apoptosis after failing selection, a feature of a reactive, benign follicle (also seen in Burkitt lymphoma).
Elsewhere in DurgiPedia
Connections
Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.
Sources: Lymph Nodes (NCI SEER Training Modules, 2024); Immune response (MedlinePlus, US National Library of Medicine, 2024); Chapter 1: Principles of Vaccination (Centers for Disease Control and Prevention (Pink Book), 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
